Antimicrobial C3a -biology, biophysics, and evolution

Advances in Experimental Medicine and Biology

Volumn 598, Issue , 2007, Pages 141-158

  Malmsten, Martin ^a   Schmidtchen, Artur ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A;

ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BIOPHYSICS; CANDIDA; CARBOXY TERMINAL SEQUENCE; CIONA INTESTINALIS; CIONA ROTUNDICAUDA; CONFERENCE PAPER; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; UROCHORDATA;

EID: 84934442934     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-71767-8_11     Document Type: Conference Paper

References (59)

1. Andersson, E., Rydengard, V., Sonesson, A., Morgelin, M., Bjorck, L., and Schmidtchen, A. (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271: 1219-1226.
2. Baev, D., Li, X.S., Dong, J., Keng, P., and Edgerton, M. (2002) Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans. Infect Immun 70: 4777-4784.
3. Boman, H.G., Agerberth, B., and Boman, A. (1993) Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61: 2978-2984.
4. Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
5. Bulet, P., Stocklin, R., and Menin, L. (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198: 169-184.
6. Caporale, L.H., Tippett, P.S., Erickson, B.W., and Hugli, T.E. (1980) The active site of C3a anaphylatoxin. J Biol Chem 255: 10758-10763.
7. Den Hertog, A.L., Wong Fong Sang, H.W., Kraayenhof, R., Bolscher, J.G., Van't Hof, W., Veerman, E.C., and Nieuw Amerongen, A.V. (2004) Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization. Biochem J 379: 665-672.
8. Epand, R.F., Ramamoorthy, A., and Epand, R.M. (2006) Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. Protein Pept Lett 13: 1-5.
9. Ganz, T. (2001) Antimicrobial proteins and peptides in host defense. Semin Respir Infect 16: 4-10.
10. Glukhov, E., Stark, M., Burrows, L.L., and Deber, C.M. (2005) Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J Biol Chem 280: 33960-33967.
11. Hallock, K.J., Lee, D.K., Omnaas, J., Mosberg, H.I., and Ramamoorthy, A. (2002) Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys J 83: 1004-1013.
12. Huber, R., Scholze, H., Paques, E.P., and Deisenhofer, J. (1980) Crystal structure analysis and molecular model of human C3a anaphylatoxin. Hoppe Seylers Z Physiol Chem 361: 1389-1399.
13. Hugli, T.E. (1990) Structure and function of C3a anaphylatoxin. Curr Top Microbiol Immunol 153: 181-208.
14. Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Nilsson-Ekdahl, K., Nilsson, B., and Gros, P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437: 505-511.
15. Kawamoto, S., Yalcindag, A., Laouini, D., Brodeur, S., Bryce, P., Lu, B., Humbles, A.A., Oettgen, H., Gerard, C., and Geha, R.S. (2004) The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J Clin Invest 114: 399-407.
16. Koshlukova, S.E., Lloyd, T.L., Araujo, M.W., and Edgerton, M. (1999) Salivary histatin 5 induces nonlytic release of ATP from Candida albicans leading to cell death. J Biol Chem 274: 18872-18879.
17. Kozel, T.R. (1996) Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 9: 34-46.
18. Kozel, T.R., Weinhold, L.C., and Lupan, D.M. (1996) Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect Immun 64: 3360-3368.
19. Lee, M.T., Hung, W.C., Chen, F.Y., and Huang, H.W. (2005) Many-body effect of antimicrobial peptides: on the correlation between lipid's spontaneous curvature and pore formation. Biophys J 89: 4006-4016.
20. Lehrer, R.I., and Ganz, T. (2002) Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 9: 18-22.
21. Lohner, K., and Blondelle, S.E. (2005) Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb Chem High Throughput Screen 8: 241-256.
22. Lu, Z.X., Fok, K.F., Erickson, B.W., and Hugli, T.E. (1984) Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peptide. J Biol Chem 259: 7367-7370.
23. Maxwell, A.I., Morrison, G.M., and Dorin, J.R. (2003) Rapid sequence divergence in mammalian beta-defensins by adaptive evolution. Mol Immunol 40: 413-421.
24. Nonaka, M., and Yoshizaki, F. (2004) Evolution of the complement system. Mol Immunol 40: 897-902.
25. Nordahl, E.A., Rydengard, V., Nyberg, P., Nitsche, D.P., Morgelin, M., Malmsten, M., Bjorck, L., and Schmidtchen, A. (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101: 16879-16884.
26. Odds, F.C. (1988) Candida and candidosis. London ; Philadelphia: Bailliére Tindall.
27. Ohki, S., Marcus, E., Sukumaran, D.K., and Arnold, K. (1994) Interaction of melittin with lipid membranes. Biochim Biophys Acta 1194: 223-232.
28. Opekarova, M., and Tanner, W. (2003) Specific lipid requirements of membrane proteins - a putative bottleneck in heterologous expression. Biochim Biophys Acta 1610: 11-22.
29. Pasupuleti, M., Walse, B., Nordahl, E.A., Morgelin, M., Malmsten, M., and Schmidtchen, A. (2006) Preservation of antimicrobial properties of complement peptide C3a - from invertebrates to humans. J Biol Chem.
30. Pinto, M.R., Chinnici, C.M., Kimura, Y., Melillo, D., Marino, R., Spruce, L.A., De Santis, R., Parrinello, N., and Lambris, J.D. (2003) CiC3-1a-mediated chemotaxis in the deuterostome invertebrate Ciona intestinalis (Urochordata). J Immunol 171: 5521-5528.
31. Pitarch, A., Sanchez, M., Nombela, C., and Gil, C. (2003) Analysis of the Candida albicans proteome. II. Protein information technology on the Net (update 2002). J Chromatogr B Analyt Technol Biomed Life Sci 787: 129-148.
32. Powers, J.P., and Hancock, R.E. (2003) The relationship between peptide structure and antibacterial activity. Peptides 24: 1681-1691.
33. Ringstad, L., Andersson Nordahl, E., Schmidtchen, A., and Malmsten, M. (2007) Composition Effect on Peptide Interaction with Lipids and Bacteria: Variants of C3a Peptide CNY21. Biophys J 92: 87-98.
34. Savolainen, J., Lammintausta, K., Kalimo, K., and Viander, M. (1993) Candida albicans and atopic dermatitis. Clin Exp Allergy 23: 332-339.
35. Schwartz, L.B., Kawahara, M.S., Hugli, T.E., Vik, D., Fearon, D.T., and Austen, K.F. (1983) Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 130: 1891-1895.
36. Selsted, M.E., Brown, D.M., DeLange, R.J., Harwig, S.S., and Lehrer, R.I. (1985) Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 260: 4579-4584.
37. Selsted, M.E., Harwig, S.S., Ganz, T., Schilling, J.W., and Lehrer, R.I. (1985) Primary structures of three human neutrophil defensins. J Clin Invest 76: 1436-1439.
38. Semple, C.A., Rolfe, M., and Dorin, J.R. (2003) Duplication and selection in the evolution of primate beta-defensin genes. Genome Biol 4: R31.
39. Shai, Y. (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66: 236-248.
40. Skarnes, R.C., and Watson, D.W. (1957) Antimicrobial factors of normal tissues and fluids. Bacteriol Rev 21: 273-294.
41. Sohnle, P.G., and Kirkpatrick, C.H. (1976) Deposition of complement in the lesions of experimental cutaneous candidiasis in guinea pigs. J Cutan Pathol 3: 232-238.
42. Sonesson, A., Ringstad, L., Andersson Nordahl, E., Malmsten, M., Morgelin, M., and Schmidtchen, A. (2006) Antifungal activity of C3a and C3a-derived peptides against Candida. Biochim Biophys Acta.
43. Steiner, H., Hultmark, D., Engström, A., Bennich, H., and Boman, H.G. (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292: 246-248.
44. Sunyer, J.O., Boshra, H., and Li, J. (2005) Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement. Vet Immunol Immunopathol 108: 77-89.
45. Taylor, J.C., Crawford, I.P., and Hugli, T.E. (1977) Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. Biochemistry 16: 3390-3396.
46. Tennessen, J.A. (2005) Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection. J Evol Biol 18: 1387-1394.
47. Wang, Y., Agerberth, B., Lothgren, A., Almstedt, A., and Johansson, J. (1998) Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 273: 33115-33118.
48. Werfel, T., Kirchhoff, K., Wittmann, M., Begemann, G., Kapp, A., Heidenreich, F., Gotze, O., and Zwirner, J. (2000) Activated human T lymphocytes express a functional C3a receptor. J Immunol 165: 6599-6605.
49. Williamson, M.P., and Madison, V.S. (1990) Three-dimensional structure of porcine C5adesArg from 1H nuclear magnetic resonance data. Biochemistry 29: 2895-2905.
50. Wright, J., Schwartz, J.H., Olson, R., Kosowsky, J.M., and Tauber, A.I. (1986) Proton secretion by the sodium/hydrogen ion antiporter in the human neutrophil. J Clin Invest 77: 782-788.
51. Yount, N.Y., Bayer, A.S., Xiong, Y.Q., and Yeaman, M.R. (2006) Advances in antimicrobial peptide immunobiology. Biopolymers.
52. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84: 5449-5453.
53. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
54. Zelezetsky, I., Pontillo, A., Puzzi, L., Antcheva, N., Segat, L., Pacor, S., Crovella, S., and Tossi, A. (2006a) Evolution of the primate cathelicidin - correlation between structural variations and antimicrobial activity. J Biol Chem.
55. Zelezetsky, I., and Tossi, A. (2006b) Alpha-helical antimicrobial peptides-Using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta.
56. Zeya, H.I., and Spitznagel, J.K. (1963) Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification. Science 142: 1085-1087.
57. Zhang, L., and Falla, T.J. (2004) Cationic antimicrobial peptides - an update. Expert Opin Investig Drugs 13: 97-106.
58. Zhang, X., Boyar, W., Toth, M.J., Wennogle, L., and Gonnella, N.C. (1997) Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy. Proteins 28: 261-267.
59. Zhu, Y., Thangamani, S., Ho, B., and Ding, J.L. (2005) The ancient origin of the complement system. Embo J 24: 382-394.